News Announcement

Bafna Pharmaceuticals: Announcement under Regulation 30 (LODR)-Change in Directorate

We hereby inform that the Members at the 30th Annual General Meeting of the Company held on September 19 2025 had inter-alia approved (i) Appointment of Mr. Navin Kumar as Independent Director of the Company and (ii) Re-appointment of Mr. Palamadai Krishnan Sundaresan and Mrs. Ravichandran Chitra as Independent Directors of the Company.

Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.